bioRxivImmunology
Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy
J. C. Martin, G. Boschetti, C. Chang, R. Ungaro, M. Giri, L.-S. Chuang, S. Nayar, A. Greenstein, M. Dubinsky, L. Walker, A. Leader, J. Fine, C. Whitehurst, L. Mbow, S. Kugathasan, L. Denson, J. Hyams, J. Friedman, P. Desai, M. Ko, I. Laface, G. Akturk, E. Schadt, S. Gnjatic, A. Rahman, , E. Kenigsberg
Abstract
Clinical benefits to cytokine blockade in ileal Crohns disease (iCD) have been limited to a subset of patients. Whether cellular and molecular heterogeneity contributes to variability in treatment responses has been unclear. Using single cell technologies combining scRNAseq, CyTOF and multiplex tissue imaging, we mapped the cellular landscape of inflamed ileum lesions, adjacent non-inflamed ileum and matched circulating blood cells of iCD patients. In inflamed tissues, we identified a pathogenic module characterized by an inflammatory mononuclear phagocyte (Inf.MNP)-associated cellular response organized around inflammatory macrophages and mature dendritic cells in a subset of iCD patients. We confirmed the Inf.MNP-associated cellular response in 4 independent iCD cohorts (n=441) and showed that presence of this pathogenic module at diagnosis correlated with primary resistance to anti-TNF therapy. Single cell mapping of iCD tissues identifies a complex cellular signature of anti-TNF resistance thereby revealing novel biomarkers of treatment response and tailored therapeutic opportunities.
- organism: human
- assay: scRNA-seq
- assay: flow cytometry
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A JAK-STAT-activated myeloid hub at ulceration sites underlies resistance to anti-TNF therapy in Crohn's disease
Thomas Laurent, Monika Mykhaylyshyn, … J. P. D. Martin·bioRxiv·Feb 13, 2026
- Cytokine interaction networks, not individual cytokines, drive anti-TNF response in Crohn's disease
Marton L. Olbei, John P. Thomas, … Tamas Douglas Korcsmaros·bioRxiv·Aug 11, 2026
- A longitudinal single-cell therapeutic atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
T. Thomas, C. Rich-Griffin, … C. Buckley·bioRxiv·May 5, 2023
- Single-Cell RNA Sequencing of Terminal Ileal Biopsies Identifies Signatures of Crohn's Disease Pathogenesis.
Monika Krzak, Tobi Alegbe, … Carl A. Anderson·Nature GeneticsPeer-reviewed·Jun 15, 2026
- Mucosal ecosystems of the ileum and colon shape the therapeutic response in Crohn's Disease
Ran RZ Zhou, Bingqing Xie, … Anindita Basu·bioRxiv·Mar 26, 2025
- Epithelial stem cell-derived chemokines track clinical remission in inflammatory bowel disease in a disease-specific manner
Sanmi E. Alake, Anil Hari Kadam, … Babajide A. Ojo·bioRxiv·May 27, 2026